Patents by Inventor Rachel Groppo

Rachel Groppo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN METAPNEUMOVIRUS VIRAL VECTOR-BASED VACCINES
    Publication number: 20240415952
    Abstract: The present disclosure provides a human metapneumovirus (hMPV) vaccine comprising an hMPV F protein antigen, and methods of eliciting an immune response by administering said vaccine.
    Type: Application
    Filed: May 22, 2024
    Publication date: December 19, 2024
    Inventors: Yvonne CHAN, Sukanya SASMAL, Antonia STUEBLER, Michael KISHKO, Sophia MUNDLE, Linong ZHANG, Josh DINAPOLI, Judith ALAMARES-SAPUAY, Natalie ANOSOVA, Sudha CHIVUKULA, Hillary DANZ, Tod STRUGNELL, Rachel GROPPO, Peter COLLINS, Ursula BUCHHOLZ, Shirin MUNIR, Bibha DAHAL
  • HUMAN METAPNEUMOVIRUS VACCINES
    Publication number: 20230310571
    Abstract: The present disclosure provides antigenic prefusion hMPV F polypeptides, nucleic acid sequences (e.g., RNA sequences, e.g., mRNA sequences) encoding prefusion hMPV F polypeptides, compositions comprising antigenic prefusion hMPV F polypeptides, compositions comprising nucleic acid sequences encoding prefusion hMPV F polypeptides, and hMPV vaccines.
    Type: Application
    Filed: November 29, 2022
    Publication date: October 5, 2023
    Inventors: Yvonne Chan, Sukanya Sasmal, Antonia Stuebler, Michael Kishko, Sophia Mundle, Linong Zhang, Josh DiNapoli, Judith Alamares-Sapuay, Natalie Anosova, Sudha Chivukula, Hillary Danz, Tod Strugnell, Rachel Groppo
  • Compositions and methods for regulating mRNA transcription and translation
    Publication number: 20050019808
    Abstract: The invention relates to compositions, specifically novel nucleic acid constructs encoding a cardiovirus 2A polypeptide operably linked to suitable promoters. Also, disclosed are methods whereby the nucleic acid constructs are introduced into cells or cell free systems to regulate cellular mRNA transcription and cap-dependent or internal ribosomal entry site (IRES)-dependent mRNA translation.
    Type: Application
    Filed: July 9, 2004
    Publication date: January 27, 2005
    Inventors: Ann Palmenberg, Aleksey Aminev, Rachel Groppo